Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Completed · Phase 2

Conditions studied: Lateral Canthal Lines, Crow's Feet, Facial Wrinkles

In brief

This study's objective is to evaluate if RT001 is safe and well-tolerated following two (2) sequential applications.

Key facts

Study ID
NCT01124565
Run by
Revance Therapeutics, Inc.
People needed
40
Starts
2010-05-01
Expected to finish
2010-07-01
Last updated by the study team
2014-01-17

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.